JP2005529847A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005529847A5 JP2005529847A5 JP2003565408A JP2003565408A JP2005529847A5 JP 2005529847 A5 JP2005529847 A5 JP 2005529847A5 JP 2003565408 A JP2003565408 A JP 2003565408A JP 2003565408 A JP2003565408 A JP 2003565408A JP 2005529847 A5 JP2005529847 A5 JP 2005529847A5
- Authority
- JP
- Japan
- Prior art keywords
- conjugate
- transporter
- pharmaceutical composition
- drug
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35180802P | 2002-01-24 | 2002-01-24 | |
| US10/351,291 US20030158254A1 (en) | 2002-01-24 | 2003-01-23 | Engineering absorption of therapeutic compounds via colonic transporters |
| PCT/US2003/002206 WO2003065982A2 (en) | 2002-01-24 | 2003-01-24 | Engineering absorption of therapeutic compounds via colonic transporters |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005529847A JP2005529847A (ja) | 2005-10-06 |
| JP2005529847A5 true JP2005529847A5 (enExample) | 2006-03-09 |
Family
ID=27737413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003565408A Withdrawn JP2005529847A (ja) | 2002-01-24 | 2003-01-24 | 結腸トランスポーターによる治療用化合物の吸収の工作 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20030158254A1 (enExample) |
| EP (1) | EP1575494A2 (enExample) |
| JP (1) | JP2005529847A (enExample) |
| KR (1) | KR20040111348A (enExample) |
| AU (1) | AU2003244398A1 (enExample) |
| CA (1) | CA2473802A1 (enExample) |
| WO (1) | WO2003065982A2 (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| AU2002310409C1 (en) * | 2001-06-11 | 2008-04-17 | Xenoport, Inc. | Orally administered dosage forms of GABA analog prodrugs having reduced toxicity |
| US7186855B2 (en) * | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| UA78529C2 (en) | 2001-10-10 | 2007-04-10 | Wyeth Corp | Derivatives of [[2-(amino-3,4-dioxo-1-cyclobutene-1-yl)amino]alkyl] acid for treating pain |
| US7378239B2 (en) * | 2002-06-25 | 2008-05-27 | Index Diagnostics Ab | Method of differentiating between ulcerative colitis and Crohn's disease |
| US7025745B2 (en) * | 2002-10-07 | 2006-04-11 | Advanced Cardiovascular Systems, Inc. | Method of making a catheter balloon using a tapered mandrel |
| US20050032135A1 (en) * | 2003-07-03 | 2005-02-10 | Xenoport, Inc. | Monocarboxylate transporters expressed in cancer cells |
| WO2005041935A1 (en) * | 2003-10-21 | 2005-05-12 | Alpharma, Inc. | Pharmaceutical formulations containing quetiapine |
| RU2006118801A (ru) * | 2003-10-31 | 2007-12-10 | Алза Корпорейшн (Us) | Композиции и лекарственные формы для усиления всасывания габапентина и прегабалина |
| WO2005074996A2 (en) * | 2004-01-30 | 2005-08-18 | Xenoport, Inc. | Lat1 transporter expressed in blood brain barrier cells |
| US7452680B2 (en) * | 2004-01-30 | 2008-11-18 | Xenoport, Inc. | MCT1 transporters expressed in blood brain barrier cells |
| US20060003920A1 (en) * | 2004-06-04 | 2006-01-05 | Xenoport, Inc. | LAT1 transporters expressed in cancer cells |
| AU2005252220B2 (en) * | 2004-06-04 | 2011-06-02 | Xenoport, Inc. | Levodopa prodrugs, and compositions and uses thereof |
| US20060003361A1 (en) * | 2004-06-04 | 2006-01-05 | Xenoport, Inc. | SMVT transporters expressed in cancer cells |
| WO2006001986A2 (en) * | 2004-06-04 | 2006-01-05 | Xenoport, Inc. | Glut3 transporters expressed in cancer cells |
| US20060003362A1 (en) * | 2004-06-04 | 2006-01-05 | Xenoport, Inc. | ENT1 transporters expressed in cancer cells |
| WO2005121070A1 (en) * | 2004-06-04 | 2005-12-22 | Xenoport, Inc. | Levodopa prodrugs, and compositions and uses thereof |
| US7348276B2 (en) * | 2005-03-30 | 2008-03-25 | Fujitsu, Limited | Fabrication process of semiconductor device and polishing method |
| CN101232868A (zh) * | 2005-04-19 | 2008-07-30 | 阿尔扎公司 | 曲马多和加巴喷丁的控释递药剂型 |
| US7241805B2 (en) * | 2005-06-27 | 2007-07-10 | Biovail Laboratories, Inc. | Modified release formulations of a bupropion salt |
| US7563821B2 (en) | 2005-12-05 | 2009-07-21 | Xenoport, Inc. | Levodopa prodrug mesylate, compositions thereof, and uses thereof |
| WO2008052044A2 (en) * | 2006-10-26 | 2008-05-02 | Xenoport, Inc. | Use of derivatives of propofol for treating diseases associated with oxidative stress |
| TW200843731A (en) * | 2006-12-21 | 2008-11-16 | Xenoport Inc | Catechol protected levodopa diester prodrugs, compositions, and methods of use |
| CA2673336A1 (en) * | 2006-12-21 | 2008-06-26 | Xenoport, Inc. | Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use |
| US8828665B2 (en) | 2007-02-16 | 2014-09-09 | Ark Diagnostics, Inc. | Compounds and methods for use in detecting gabapentin |
| TW200924746A (en) * | 2007-09-07 | 2009-06-16 | Xenoport Inc | Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
| US20090099253A1 (en) * | 2007-10-15 | 2009-04-16 | Xenoport, Inc. | Internally Masked Neopentyl Sulfonyl Ester Cyclization Release Prodrugs of Acamprosate, Compositions Thereof, and Methods of Use |
| CA2747253A1 (en) * | 2007-12-20 | 2009-07-02 | Index Diagnostics Ab | Method and kit for use in the differentiation of ibd and ibs and further distinction between disease types of ibd |
| US8399513B2 (en) * | 2008-10-20 | 2013-03-19 | Xenoport, Inc. | Levodopa prodrug mesylate hydrate |
| US9290445B2 (en) * | 2008-10-20 | 2016-03-22 | Xenoport, Inc. | Methods of synthesizing a levodopa ester prodrug |
| US8168756B2 (en) | 2008-10-24 | 2012-05-01 | Ark Diagnostics, Inc. | Levetiracetam immunoassays |
| CA2789236C (en) | 2009-11-09 | 2014-09-09 | Xenoport, Inc. | Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use |
| WO2014113717A1 (en) | 2013-01-18 | 2014-07-24 | Ark Diagnostics, Inc. | Voriconazole immunoassays |
| WO2014126861A1 (en) | 2013-02-13 | 2014-08-21 | Ark Diagnostics, Inc. | Posaconazole immunoassays |
| CA3184236A1 (en) * | 2020-07-01 | 2022-01-06 | Tyler White | Dietary composition and method |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2504010B1 (fr) * | 1981-04-15 | 1985-10-25 | Sanofi Sa | Medicaments anticancereux contenant la chaine a de la ricine associee a un anticorps antimelanome et procede pour leur preparation |
| US4671958A (en) * | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
| US4542225A (en) * | 1984-08-29 | 1985-09-17 | Dana-Farber Cancer Institute, Inc. | Acid-cleavable compound |
| US4590071A (en) * | 1984-09-25 | 1986-05-20 | Xoma Corporation | Human melanoma specific immunotoxins |
| US4659839A (en) * | 1984-10-10 | 1987-04-21 | Mallinckrodt, Inc. | Coupling agents for radiolabeled antibody fragments |
| US4680338A (en) * | 1985-10-17 | 1987-07-14 | Immunomedics, Inc. | Bifunctional linker |
| US4699784A (en) * | 1986-02-25 | 1987-10-13 | Center For Molecular Medicine & Immunology | Tumoricidal methotrexate-antibody conjugate |
| US5563250A (en) * | 1987-12-02 | 1996-10-08 | Neorx Corporation | Cleavable conjugates for the delivery and release of agents in native form |
| US4904474A (en) * | 1988-01-25 | 1990-02-27 | Alza Corporation | Delivery of drug to colon by oral disage form |
| IT1251153B (it) * | 1991-08-06 | 1995-05-04 | Vectorpharma Int | Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica |
| ZA953078B (en) * | 1994-04-28 | 1996-01-05 | Alza Corp | Effective therapy for epilepsies |
| ATE277739T1 (de) * | 1996-10-28 | 2004-10-15 | Gen Mills Inc | Einbettung und einkapselung von teilchen zur kontrollierten abgabe |
| IL119890A (en) * | 1996-12-24 | 2002-03-10 | Teva Pharma | Gabapentin form iii and preparation of gabapentin form ii |
| US6652864B1 (en) * | 1998-12-21 | 2003-11-25 | Asilomar Pharmaceuticals, Inc. | Compounds for intracellular delivery of therapeutic moieties to nerve cells |
-
2003
- 2003-01-23 US US10/351,291 patent/US20030158254A1/en not_active Abandoned
- 2003-01-24 CA CA002473802A patent/CA2473802A1/en not_active Abandoned
- 2003-01-24 KR KR10-2004-7011457A patent/KR20040111348A/ko not_active Withdrawn
- 2003-01-24 JP JP2003565408A patent/JP2005529847A/ja not_active Withdrawn
- 2003-01-24 EP EP03737554A patent/EP1575494A2/en not_active Withdrawn
- 2003-01-24 WO PCT/US2003/002206 patent/WO2003065982A2/en not_active Ceased
- 2003-01-24 AU AU2003244398A patent/AU2003244398A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3662942B2 (ja) | 持続性放出甲状腺作用性組成物 | |
| ES2256335T3 (es) | Combinacines sinergisticas que comprenden un inhibidor de la renina para el tratamiento de enfermedades cardiovasculares. | |
| Birudaraj et al. | Advances in buccal drug delivery | |
| CN117337174A (zh) | 用于治疗癌症的包含cbd或thc的透皮药物制剂 | |
| CN109310653A (zh) | 用于控制释放半胱胺和系统治疗半胱胺敏感性病症的组合物 | |
| ES2530719T3 (es) | Formulaciones de oxicodona para ser administradas una vez al día | |
| CA2527646A1 (en) | Abuse resistant amphetamine compounds | |
| JP6049624B2 (ja) | 苦味のある薬物のための経口用医薬フィルム製剤 | |
| SA95160287A (ar) | مركب صيدلي جديد للتعاطي بطريق الفم | |
| RU2011115418A (ru) | Усиление действия противораковых агентов | |
| IL173078A0 (en) | Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form | |
| EA200800161A1 (ru) | Новые фармацевтические композиции с модифицированным высвобождением и способ получения таких композиций | |
| WO2003065982A3 (en) | Engineering absorption of therapeutic compounds via colonic transporters | |
| JP2010518086A5 (enExample) | ||
| JP2006513184A5 (enExample) | ||
| US20050065086A1 (en) | Use of peptide-drug conjugation to reduce inter-subject variability of drug serum levels | |
| CA3041857A1 (en) | Disulfiram and metal salt staggered oral dosing regimen and staggered-release oral unit dosage forms | |
| ATE380545T1 (de) | Pharmazeutische zubereitung mit verzögerter freisetzung zur oralen wirkstoffverabreichung | |
| WO2004112838A3 (en) | Codrugs of diclofenac | |
| US20070298098A1 (en) | Controlled Release Compositions Comprising Levetiracetam | |
| CN103237785A (zh) | 增强的经颊药物递送系统和组合物 | |
| US20220233435A1 (en) | Controlled release device for oral cavity | |
| CA2516327A1 (en) | Therapeutic system comprising amoxicillin and clavulanic acid | |
| RU2006142101A (ru) | Способ снижения желудочно-кишечной токсичности, возникающей в результате применения тегафура | |
| JP2014503589A5 (enExample) |